Prosztatarák: vizsgálatok itt: Dánia
34 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleStudy of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
- Where
- Copenhagen Oe, Odense C, Vejle
- Életkor
- 18 év and over
- People
- 1310 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06136624 · EU 2023-504899-25-00 - 1. fázisCsak meghívásosA Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring
- Where
- Copenhagen Oe, Odense C
- Életkor
- 18 év and over
- People
- 120 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06788509 · EU 2024-515457-21-00 - 3. fázisTaking peopleA Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
- Where
- Næstved, Odense C, Vejle
- Életkor
- 18 év and over
- People
- 900 worldwide
- Run by
- Pfizer
See details and how to joinNCT06629779 · EU 2024-511652-40-00 - 3. fázisTaking peopleA Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
- Where
- Aalborg, Herlev, Odense C, Vejle
- Életkor
- 18 év and over
- People
- 1440 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06925737 · EU 2024-517423-40-00 - 1/2. fázisTaking peopleStudy of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors
- Where
- Odense C
- Életkor
- 18 év and over
- People
- 205 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07288359 - 1/2. fázisTaking peopleAn Open-label Dose Escalation and Expansion, Followed by a Phase II Study of Tulmimetostat (DZR123) and JSB462 (Luxdegalutamide) in Patients With Progressive Metastatic Castrate Resistant Prostate Cancer (mCRPC) (TulmiSTAR-01)
- Where
- Herlev, Odense C, Vejle
- Életkor
- 18 év and over
- People
- 188 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07206056 · EU 2025-521880-10-00 - 3. fázisTaking peopleImpact of atorvastatin on prostate cancer progression after initiation of androgen deprivation therapy
- Where
- Århus, Copenhagen Oe, Herlev, Odense C
- Életkor
- 18 év and over
- People
- 400 worldwide
- Run by
- Pirkanmaan hyvinvointialue
See details and how to join2024-517854-91-00 · EU 2024-517854-91-00 - No phaseCsak meghívásosMultiparametric MRI in Men With Prostate Cancer Undergoing Active Surveillance
- Where
- Herlev
- Életkor
- 18 év to 75 év
- People
- 150
- Run by
- Herlev Hospital
See details and how to joinNCT02526797 - No phaseCsak meghívásosMultiparametric MRI in Men With Prostate Cancer Enrolled in Active Surveillance
- Where
- Herlev
- Életkor
- 18 év to 75 év
- People
- 200
- Run by
- Herlev Hospital
See details and how to joinNCT03648359 - No phaseCsak meghívásosCancer of the Prostate Treated With Focal Implantation of a RadioactivE Source
- Where
- Herlev
- Életkor
- 18 év to 80 év
- People
- 50
- Run by
- Herlev Hospital
See details and how to joinNCT06080113 - 2. fázisTaking peopleCannabidiol for Pain Relief of Patients With End-stage mCRPC
- Where
- Gistrup
- Életkor
- 18 év and over
- People
- 58
- Run by
- Regionshospital Nordjylland
See details and how to joinNCT07549256 · EU 2024-513951-33-00 - 3. fázisTaking peopleImmediate Curative vs Conservative Treatment in Older Men With M0, High-risk Prostate Cancer
- Where
- Copenhagen, Esbjerg, Odense
- Életkor
- 75 év and over
- People
- 980 worldwide
- Run by
- Sven Löffeler
See details and how to joinNCT05448547 - 2. fázisTaking peopleA Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study
- Where
- Odense C
- Életkor
- 18 év and over
- People
- 37 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT04641247 · EU 2023-506618-29-00 - No phaseNot yet taking people in DániaMR-guided Single-fraction SBRT for Nodal Oligorecurrent Prostate Cancer (PINPOINT)
- Where
- Odense
- Életkor
- 18 év and over
- People
- 48
- Run by
- Odense University Hospital
See details and how to joinNCT07635108 - 2. fázisTaking peopleSafety and Diagnostic Performance of uPAR PET Imaging in Localised, Untreated Prostate Cancer
- Where
- Aalborg, Herlev, Vejle
- Életkor
- 18 év and over
- People
- 168 worldwide
- Run by
- Curasight
See details and how to joinNCT06474806 · EU 2023-507111-35-00 - No phaseTaking peopleHolistic Acupuncture for Patients With Chemotherapy Induced Nausea
- Where
- Vejle
- Életkor
- 18 év and over
- People
- 90
- Run by
- Vejle Hospital
See details and how to joinNCT07201194 - No phaseTaking peopleThe MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
- Where
- Odense
- Életkor
- 18 év and over
- People
- 8000 worldwide
- Run by
- UMC Utrecht
See details and how to joinNCT04075305 - No phaseTaking peopleAddition of Focal Boost to Primary Radiotherapy for Prostate Cancer in 12 or 20 Fractions
- Where
- Aarhus, Copenhagen, Vejle
- Életkor
- 18 év and over
- People
- 1016
- Run by
- Copenhagen University Hospital, Rigshospitalet
See details and how to joinNCT07343349 - No phaseTaking peopleGUidance In Prostate Cancer DEtection With 18F-PSMA-1007-PET/MRI and Targeted Biopsies
- Where
- Aarhus N, Herning
- Életkor
- 18 év and over
- People
- 100
- Run by
- Mads Ryo Jochumsen
See details and how to joinNCT07258056 - No phaseTaking peopleA Multi-center Investigation of Family Health.
- Where
- Odense C
- Életkor
- 18 év and over
- People
- 240
- Run by
- Odense University Hospital
See details and how to joinNCT06433349 - 3. fázisTaking peopleIntermittent Androgen Deprivation Therapy in the Era of AR Pathway Inhibitors
- Where
- Copenhagen Oe, Herlev
- Életkor
- 18 év to 100 év
- People
- 1600 worldwide
- Run by
- European Organisation for Research and Treatment of Cancer - EORTC
See details and how to joinNCT05974774 · EU 2023-506817-23-01 - No phaseTaking peoplePrehabilitation to Patients With Prostate Cancer
- Where
- Esbjerg, Nyborg, Vejle
- Életkor
- 18 év and over
- People
- 20
- Run by
- Odense University Hospital
See details and how to joinNCT07162987 - 2. fázisTaking peopleEbastine in combination with docetaxel or as a treatment for metastatic castration-resistant prostate cancer
- Where
- Copenhagen Oe, Frederiksberg
- Életkor
- 18 év and over
- People
- 30
- Run by
- Rigshospitalet
See details and how to join2024-518035-11-01 · EU 2024-518035-11-01 - No phaseNot yet taking people in DániaReminder App to Optimize Bladder Filling During Radiotherapy for Prostate Cancer
- Where
- Vejle
- Életkor
- 18 év and over
- People
- 28 worldwide
- Run by
- University Hospital Schleswig-Holstein
See details and how to joinNCT06653751 - 1/2. fázisTaking peopleEbastine in Combination With Docetaxel as a Treatment for Castration-resistant Metastatic Prostate Cancer
- Where
- Copenhagen
- Életkor
- 18 év and over
- People
- 30
- Run by
- Copenhagen University Hospital, Rigshospitalet
See details and how to joinNCT06480110